Cargando…

IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation

BACKGROUND: Pancreatic carcinoma (PC) is a highly lethal cancer with an increasing mortality rate, its five‐year survival rate is only approximately 4%. N6‐methyladenosine (m6A) modification is the most common posttranscriptional modification of RNA, it could affect tumor formation by regulating m6A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Pei, Wu, Yufan, Sun, Ding, Zhang, Weigang, Qiu, Junyi, Tang, Zuxiong, Xue, Xiaofeng, Qin, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972174/ https://www.ncbi.nlm.nih.gov/pubmed/35908253 http://dx.doi.org/10.1002/cam4.5096

Ejemplares similares

m(6)A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability
por: Liu, Hongjiang, et al.
Publicado: (2021)

Recognition of RNA N(6)-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation
por: Huang, Huilin, et al.
Publicado: (2018)

m(6)A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization
por: Lang, Chuandong, et al.
Publicado: (2021)

EGR2-mediated regulation of m(6)A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization
por: Ying, Yufan, et al.
Publicado: (2021)

IGF2BP2 acts as a m(6)A modification regulator in laryngeal squamous cell carcinoma through facilitating CDK6 mRNA stabilization
por: Tang, Xiaojun, et al.
Publicado: (2023)

IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression
por: Zhang, Lin, et al.
Publicado: (2021)

IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification
por: Li, Simeng, et al.
Publicado: (2023)

IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m(6)A-dependent manner
por: Chen, Li-Jie, et al.
Publicado: (2023)

IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N(6)-methyladenosine-dependent binding
por: Zhang, Junzhe, et al.
Publicado: (2022)

An oncopeptide regulates m(6)A recognition by the m(6)A reader IGF2BP1 and tumorigenesis
por: Zhu, Song, et al.
Publicado: (2020)

m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma
por: Fang, Han, et al.
Publicado: (2023)

RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA
por: Fan, Jin, et al.
Publicado: (2023)

METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner
por: Lu, Jiawei, et al.
Publicado: (2023)

m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs
por: Ding, Lu, et al.
Publicado: (2022)

The m6A reader IGF2BP3 preserves NOTCH3 mRNA stability to sustain Notch3 signaling and promote tumor metastasis in nasopharyngeal carcinoma
por: Chen, Boyu, et al.
Publicado: (2023)

Long noncoding RNA CERS6‐AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA
por: Bao, Gang, et al.
Publicado: (2019)

Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer’s disease
por: Deng, Yanyao, et al.
Publicado: (2021)

The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability
por: Zhang, Nan, et al.
Publicado: (2022)

LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
por: Hou, Pingfu, et al.
Publicado: (2021)

RNA binding protein IGF2BP1 meditates oxidative stress-induced granulosa cell dysfunction by regulating MDM2 mRNA stability in an m(6)A-dependent manner
por: Mu, Hongbei, et al.
Publicado: (2022)

CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m(6)A-modified CREB1 mRNA
por: Yao, Bing, et al.
Publicado: (2022)

Correction to: LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
por: Hou, Pingfu, et al.
Publicado: (2021)

The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers
por: Wang, Jinyan, et al.
Publicado: (2021)

HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m(6)A-MYC expression
por: Hu, Chenchen, et al.
Publicado: (2022)

IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer
por: Ouyang, Jun, et al.
Publicado: (2022)

RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner
por: Yu, Dan, et al.
Publicado: (2022)

The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ
por: Wang, Xia, et al.
Publicado: (2021)

IGF2BP3 mediates the mRNA degradation of NF1 to promote triple‐negative breast cancer progression via an m6A‐dependent manner
por: Zhang, Xu, et al.
Publicado: (2023)

m(6)A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma
por: Wu, Hansheng, et al.
Publicado: (2022)

Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma
por: Waly, Amr A., et al.
Publicado: (2019)

Two Isoforms of the mRNA Binding Protein IGF2BP2 Are Generated by Alternative Translational Initiation
por: Le, Hang T. T., et al.
Publicado: (2012)

Imp/IGF2BP levels modulate individual neural stem cell growth and division through myc mRNA stability
por: Samuels, Tamsin J, et al.
Publicado: (2020)

Tagged actin mRNA dysregulation in IGF2BP1 [Formula: see text] mice
por: Núñez, Leti, et al.
Publicado: (2022)

Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer
por: Ye, Mujie, et al.
Publicado: (2023)

LCAT1 is an oncogenic LncRNA by stabilizing the IGF2BP2-CDC6 axis
por: Yang, Juze, et al.
Publicado: (2022)

METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma
por: Li, Ting, et al.
Publicado: (2019)

Comment on: The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ
por: Schymik, Hanna S., et al.
Publicado: (2022)

Hakai is required for stabilization of core components of the m(6)A mRNA methylation machinery
por: Bawankar, Praveen, et al.
Publicado: (2021)

m(6)A Modification of Long Non-Coding RNA HNF1A-AS1 Facilitates Cell Cycle Progression in Colorectal Cancer via IGF2BP2-Mediated CCND1 mRNA Stabilization
por: Bian, Yibo, et al.
Publicado: (2022)

IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression
por: Wang, Cuicui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a150bpesund7d8m4q6e4d6btfg